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Abstract: The da Vinci Surgical robot has been marketed since 1999; it was originally designed 
for aiding complex laparoscopic operations and cardiac operations. By the mid-2000s, otolar-
yngologists had been attempting to deploy the surgical robot for endoscopic minimally invasive 
operations in the upper aerodigestive tract. The development went through a mannequin model, 
canine model, and cadaver model and finally cumulated to human Phase I trial. The operation 
was dubbed transoral robotic surgery (TORS). Subsequently, multicenter trials in the United 
States had proved the safety and oncological efficacy of using the surgical robot for resection 
of early cancers in the upper aerodigestive tract. In 2009, the US Food and Drug Administration 
granted license for the da Vinci surgical robot to be used for resection of benign tumors and 
early cancers in the oropharynx, larynx, and hypopharynx. TORS has also developed for surgery 
in the anterior skull base and nasopharynx, as well as in setting of flaps for reconstruction in 
the upper aerodigestive tract. This article will review the development of TORS, the current 
limitations, and future developments.
Keywords: head and neck surgery, minimally invasive surgery, computer aided surgery, endo-
scopic surgery
Introduction
Technology has been the driving force of medical advances. The introduction of the 
charged coupled device that was small enough to adapt to a rigid endoscopy enabled 
images of the internal organs inside the abdomen viewed by a laparoscope to be 
displayed on a television monitor screen. This led to the development of the first lap-
aroscopic cholecystectomy in 1998 and endoscopic surgery has become the standard 
of care for a variety of diseases in many subspecialties.
Telemanipulation is a technology that enabled the movement of a remote effector 
(robot) to copy the movement of the operator. It is the basis of robotic arms.  Raymond 
Geortz developed the first robotic arm with master and slave configuration for handling of 
radioactive substance in the Argonne National Laboratory in Chicago, USA, in 1951. 
The combination of the two technologies of remote visualization and telemanipula-
tion formed the core technology of the da Vinci surgical robot. The da Vinci surgical 
robot was developed by Intuitive Surgical Inc. (Sunnyvale, CA, USA). The company 
was founded in 1995 and the first clinical application was performed in March 1997. 
The operation was a laparoscopic cholecystectomy.1 The da Vinci surgical robot was 
marketed in 1999 and obtained approval for clinical use in laparoscopic surgery by 
the Food and Drug Administration of USA (FDA) in 2000.
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The da Vinci surgical robot consisted of a control console 
and a patient cart. The patient cart had three and later four 
robotic arms that control the instruments inserted into the 
patient, and the patient cart is placed near the patient at the 
side of the operating table. One arm is reserved for control-
ling the endoscope for visualization. The surgeon sits on the 
control console, which is placed at a distance from the patient 
but inside the operation room. The surgeon would be able to 
visualize the view of the endoscope on the control console 
and control the movements of the robotic arms.
The da Vinci surgical robot is designed to be an augmen-
tation of conventional laparoscopic surgery. In conventional 
laparoscopic surgery, the distal ends of the instruments are 
usually not articulated. Even if they are articulated, simultane-
ous control of all the joints would be difficult. Therefore, in 
conventional laparoscopic surgery, some degree of movement 
will need to be sacrificed. The major advantage of the da 
Vinci surgical robot is the incorporation of the EndoWrist®, 
which allowed 7 degrees of movement and 540 degrees of 
arm rotation. The distal articulation of the wristed instru-
ment has a larger range of motion than a human wrist and is 
miniaturized to allow placement in tight spaces.
The other advantages of the da Vinci surgical robot 
include three-dimensional images, motion scaling for precise 
movements of the instruments, tremor filtration, and lack 
of fatigue.2 Remote surgery and remote proctoring are also 
added advantages in certain locations in the world where 
expertise may not be directly accessible.
Two years after the da Vinci surgical robot had been 
marketed, substantial experience was gained in abdominal 
surgery.2 After a decade of development, the use of the 
da Vinci surgical robot in minimally invasive surgery has 
shown advantages in the field of urology,3 gynecology,4 and 
colorectal surgery.5
The da Vinci surgical robot is not designed primarily 
for head and neck surgery, but head and neck surgeons 
have shown interest in adapting the da Vinci surgical robot 
to perform minimally invasive surgery or remote-access 
surgery. The use of the da Vinci surgical robot in the head 
and neck area can be divided into: 1) minimally invasive 
surgery where the surgical robot is used to perform surgi-
cal operations inside the upper aerodigestive tract without 
transgressing the normal tissue of the head and neck region; 
and 2) remote access surgery to perform surgery in the neck 
through incisions placed away from the organ in cosmetically 
acceptable regions of the neck.
The present article is a review of the current state of robot 
surgery in the head and neck region, mainly focusing on the 
application of the da Vinci surgical robot. PubMed was the 
primary database consulted in preparing this review and all 
the literature reviewed was in English. The review is not con-
ducted as an exhaustive literature search like a meta-analysis, 
but is intended to provide an overview of the current state of 
robotic surgery in the head and neck region. Table 1 lists the 
robotic procedures mentioned in the review.
Application of the da Vinci surgical 
robot in upper aerodigestive tract
McLeod and Melder performed the first application of the 
da Vinci surgical robot in endolaryngeal surgery in 2002.6 
The robot was used to resect a vallecular cyst. The case was 
a proof of concept, opening up the use of the robot in the 
field of head and neck surgery.
Subsequently, extensive research on application of the da 
Vinci surgical robot in performing endoscopic surgery in the 
oropharynx, larynx, and hypopharynx was performed by the 
University of Pennsylvania group. The study started on an air-
way mannequin,7 progressing to cadaveric dissections,8–10 and 
later to a canine model.11,12 After the success in the preclinical 
phase of the study, the group embarked on Phase I clinical trials 
in 2006 with case series on resection of base of tongue can-
cers,8 tonsillar cancers,13 and supraglottic cancers.14 The FDA 
approved the use of the da Vinci surgical robot for endoscopic 
resection of early T-stage (T1–T2) head and neck cancers in 
2009. The operation was subsequently named “transoral robotic 
surgery” (TORS). Subsequently, other centers applied TORS 
for resection of early cancers in the hypopharynx.15
Several centers subsequently showed that TORS resection 
of early stage cancer of the upper aerodigestive tract was tech-
nically feasible and TORS resection was able to obtain clear 
resection margins.13,16–18 The quoted advantage of TORS com-
pared to other endoscopic resection methods like endoscopic 
laser surgery included better access to tumors. The angled 
endoscope and EndoWrist® allowed access to tumors outside 
the line of sight, which would not be accessible with traditional 
endoscopic instruments and CO
2
 laser. After an initial learning 
phase, the operating time including robot setup time was com-
parable to traditional endoscopic surgery. The postoperative 
recovery, including time to return to oral diet and hospital stay, 
was also comparable. Figures 1–5 illustrate a typical case of 
robotic tonsillectomy for T1 cancer of the tonsil.
TORS and laser surgery are not mutually exclusive 
technologies. Several centers had adapted the use of fiber 
laser delivery with the da Vinci robot in resection of 
oropharyngeal, laryngeal, and hypopharyngeal lesions. The 
advantages of the laser included precise incision, minimal 
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Figure 1 view of the setup of the patient and the da vinci surgical robot for robotic 
radical tonsillectomy.
Figure 2 view of the patient and the robotic arms during robotic radical 
tonsillectomy.
Notes: The bedside surgical assistant’s hand can be seen on the left of the photo, 
holding a suction. From the view of the video monitor, the tip of the suction can be 
seen inside the patient’s oral cavity, evacuating smoke and blood.
Figure 3 Screen capture of the robotic radical right tonsillectomy showing division 
of the superior constrictor muscles with the monopolar cautery diathermy spatula.
Note: The other robotic arm was retracting the tonsil medially.
Figure 4 immediate postoperative view of the surgical defect after robotic radial 
tonsillectomy.
Note: The defect would be left for healing with secondary intention.
adjacent tissue damage, and excellent tissue hemostasis.19–22 
The EndoWrist® and angled telescope of the da Vinci surgi-
cal robot allow delivery of laser to areas previously not able 
to be reached by traditional delivery methods like transoral 
laser microscopic surgery.
Short-term oncological results of TORS have been 
shown to be comparable to other treatment methods like 
radical resection or concurrent chemoradiotherapy in several 
centers. Most of the short-term oncological outcomes were 
reports on the results of treating oropharyngeal cancers.23–31 
 Unfortunately, a high proportion of the patients in the above 
cohorts received postoperative radiotherapy or chemoradio-
therapy, usually due to advanced nodal diseases. This makes 
it difficult to analyze the additional oncological effect of 
TORS as a treatment.
In the West, oropharyngeal cancer became the dominant 
type of cancer in the upper aerodigestive tract from the year 
2000.32 The majority of the oropharyngeal cancers harbor 
the human papilloma virus (HPV).33 Ang et al showed that 
HPV-related oropharyngeal cancer had a markedly improved 
survival after definitive treatment with chemoradiotherapy, and 
HPV was shown to be a strong and independent prognostic 
factor in oropharyngeal cancer.34 The 3-year overall survival 
of the HPV-positive oropharyngeal cancer patients in Ang’s 
cohort was 82.4%, compared to 57.1% in the HPV-negative 
patients. Primary chemoradiotherapy was shown to affect the 
swallowing function of the patients to an extent that the patient 
could become feeding-tube dependent.33,35,36 Higher dose of 
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Figure 5 Photo of the radical tonsillectomy specimen.
radiotherapy and the addition of chemotherapy were shown 
to be a predictor of poor swallowing outcome.34,36,37 As the 
survival of HPV-related oropharyngeal cancer is excellent, 
minimizing the long-term complications after treatment is 
necessary.
Advocates of TORS and primary surgical treatment 
argued that with primary surgery (TORS or other methods) 
to resect the local disease, and conservative neck dissec-
tion to control nodal disease, a significant portion of the 
patients can avoid high-dose radiotherapy or the addition of 
chemotherapy. This would in turn lead to a better long-term 
swallowing outcome. This is the advantage of incorporating 
TORS in the overall management of HPV-related oropharyn-
geal cancer, which is otherwise managed equally well with 
chemoradiotherapy in terms of survival outcome. Phase II 
randomized clinical trials are now ongoing or under planning 
to define the role of TORS in HPV-related and HPV-unrelated 
cancer of the oropharynx.38
There are fewer reports on the oncological efficacy 
of TORS in management of laryngeal cancer.14,39–42 The 
reported cohorts were of smaller size with a median of 
nine patients (range three to 18). All resections in the five 
cohorts achieved negative surgical margins. The initial 
outcomes were comparable to other modalities of treatment 
but there were no obvious advantages compared with other 
modalities of treatment like transoral laser microsurgery. 
A large multicenter report on the experience of TORS on 
82 laryngeal cancers commented that only a small portion 
of patients would not be able to receive transoral laser 
microsurgery.17
To date, there are two reports on performing total laryn-
gectomy with the da Vinci surgical robot, but both are small 
case series with no oncological outcome measurement.43,44 
The advantage of robotic total laryngectomy is unknown at 
present.
Oncological results for TORS resection of hypopharyn-
geal cancers are also lacking. The largest series consisted 
of 23 patients with 16 T1–T2 tumors.45 Sixty-nine percent 
received adjuvant radiotherapy or chemoradiotherapy. The 
3-year overall survival was 89%. Lörincz et al reported 
their experience in five patients using TORS to resect early 
(T1–T2) cancer of the pyriform fossa.46 They were able to 
achieve en bloc resection with at least 4 mm microscopic 
clear margins.
For TORS to be a successful minimally invasive surgery, 
the functional outcome should be as important as the onco-
logical outcome. The majority of the functional outcome 
studies concentrated on swallowing function, as dysphagia 
is the main long-term morbidity of the alternative organ 
preservation treatments. The majority of the functional 
outcome reports are from TORS resection of oropharyngeal 
cancer. Hutcheson et al published a systematic review of the 
functional outcome after TORS for oropharyngeal cancer 
in 2014.47 The review included 12 trials with 441 patients. 
The conclusion was that patients who underwent TORS for 
oropharyngeal cancer had a lower gastrostomy utilization rate 
when compared to published benchmarks of radiotherapy 
or chemoradiotherapy cohorts. The subjective swallowing 
symptom scores for TORS patients were comparable to 
radiotherapy cohorts.
Richmon et al reported an analysis of 9,601 patients 
treated for oropharyngeal cancer with ablative surgery 
from 2008–2009 in the USA from the discharge data of the 
 Nationwide Inpatient Sample.48 TORS was associated with 
shorter hospital stay (mean -1.5 days) and lower hospital 
related costs (mean -US$4,285) after controlling for comor-
bidities, extent of surgery, and type of hospital. The study did 
not factor in the capital cost of the da Vinci surgical robot so 
it was difficult to extrapolate the real cost saving. The study 
also showed that patients who received TORS had a lower 
rate of gastrostomy and tracheostomy when compared with 
other surgical ablative procedures. Chung et al reported a 
nationwide analysis of clinical and cost outcome of TORS 
for oropharyngeal and oral tongue cases from 2008–2011 
in the United States, and showed that TORS lateral oropha-
ryngectomy and tongue base resection had clinical and cost 
benefits. There was no benefit with using the robot for oral 
tongue cancer.49
An emerging unique application of TORS in the manage-
ment of head and neck malignancies is in the workup of the 
metastatic neck lymph node of unknown primary. Mehta 
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et al first reported a case series of ten patients with metastatic 
neck lymph node of unknown primary who underwent TORS 
resection of base of tongue, and the primary cancer was iden-
tified in nine out of ten cases.50 Abuzeid et al reported a case 
of identifying the primary cancer in the base of tongue after 
TORS resection of base of tongue, and argued that the ability of 
TORS to identify the primary would spare patients from wide-
field irradiation if the primary was unable to be identified.51 
Durmus et al showed in their cohort of 22 patients that the use 
of TORS tonsillectomy and base of tongue resection as part of 
the diagnostic and therapeutic procedure for unknown primary 
had excellent short-term quality of life outcome.52 Literature is 
still lacking in comparison of the incorporation of TORS versus 
standard workup of endoscopy and imaging in the workup of 
metastatic neck lymph node of unknown primary.
Apart from ablative surgery, the da Vinci surgical robot 
has also been employed in reconstruction of defects in the 
upper aerodigestive tract after resection of the primary 
tumor. Selber et al demonstrated in the dissection labora-
tory the feasibility of insetting a microvascular free flap in 
the oropharynx and microvascular anastomosis of the free 
flap in a cadaver.53 The advantage of the da Vinci surgical 
robot in flap inset was the ability to visualize and suture in 
the confined space of the base of tongue and oropharyngeal 
wall, while the disadvantage was the lack of tactile sensation 
in tying knots, requiring the surgeon to use vision to inspect 
the tightness of the knots. Since then, Selber et al and other 
groups have published their case series on robotic inset of 
free flaps.54–57
Despite the widespread use of TORS, robotic-assisted 
reconstructions of head and neck defects have not gained 
popularity. Apart from the additional cost incurred with 
using the robot, there are several reasons for the lack of 
popularity of robotic-assisted reconstructions in the head and 
neck region. Firstly, lesions resected with TORS are usually 
small and healing by primary closure,58 secondary intention, 
or local rotational mucosal flap would be adequate. Larger 
tumors are usually contraindicated for the TORS approach 
and are usually resected with traditional transcervical 
approaches with or without mandibulotomy. These defects 
would then be reconstructed in a traditional way. Secondly, 
the loss of tactile sensation may not be compensated by the 
superior visualization offered by the robot. Thirdly, the da 
Vinci surgical robot is still bulky and takes time to set up 
in preparation for use in flap insetting and microvascular 
anastomosis. Surgeons may not be willing to add this extra 
setup time in these already long operations, though Katz et al 
argued that the setup time for the robot is similar to the setup 
time of the microscope.59 Lastly, tremor of the surgeon during 
microvascular anastomosis is not an insurmountable obstacle 
and, with practice, most microvascular surgeons would be 
able to overcome hand tremor and perform microvascular 
surgery well. The benefit of tremor filtration offered by the 
da Vinci surgical robot may be marginal.
Apart from application in head and neck oncology, the da 
Vinci surgical robot has also been used for benign conditions 
of the head and neck region, most commonly for the resec-
tion of hypertrophic tongue base tissue in obstructive sleep 
apnea syndrome (OSAS). Principles and setup for TORS 
resection of base of tongue can be easily adapted to resect 
hypertrophied lingual tonsils in patients with OSAS. Several 
reports have been published in the literature on the use of 
the da Vinci surgical robot for resection of base of tongue 
and other redundant oropharyngeal soft tissue in OSAS.60–63 
Further research is required to compare the efficacy and 
cost–benefit ratio in using the robot in comparison to other 
modalities like radiofrequency ablation and coblation lingual 
tonsillectomy. The risks associated with TORS procedures in 
OSAS are similar to other procedures in sleep apnea surgery,64 
and special monitoring and nursing care need to be offered in 
the postoperative period to maximize patient safety.65
Application of the da Vinci surgical 
robot in the nasopharynx and skull 
base
Endoscopic endonasal surgery has gained signif icant 
advancements in the past 2 decades due to the improvement 
in surgical instruments and increased understanding of the 
endoscopic anatomy of the nasal cavities, paranasal sinuses, 
anterior skull base, and central skull base. Currently, a two 
surgeon four hands technique is a standard approach for 
endoscopic endonasal resection of skull base lesions.66 The 
next logical step in endoscopic endonasal surgery is the 
application of robotic surgery.67
The first preclinical trial on the use of the da Vinci surgical 
robot in the skull base was started in 2005 by the University 
of Pennsylvania group.68 They performed cadaveric dissec-
tions and showed the feasibility of using the robot to dissect 
in the parapharyngeal space and infratemporal fossa. The 
access to the parapharyngeal space and infratemporal fossa 
was through a transoral route with incision of the ipsilateral 
tonsillar pillar. They also noted that the absence of bone 
instruments would hamper resection of lesions involving the 
bony skull base. The group later described their case series 
of resecting benign tumors in the parapharyngeal space with 
the robot.69
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Hanna et al described their approach to the anterior 
and central skull base using the da Vinci surgical robot on 
cadaveric dissection.70 Instead of employing a pure transoral 
approach, they created two “ports” on the anterior maxil-
lary wall by two sublabial incisions and bilateral maxillary 
antrostomies (Caldwell-Luc approach). The middle meatal 
antrostomies of the maxillary sinuses were enlarged and the 
robotic arm could be advanced into the nasal cavity to reach 
the skull base. The endoscope was inserted into the nasal 
cavity through one of the nostrils. They demonstrated resec-
tion of lesions in the pituitary fossa, planum sphenoidale, 
nasopharynx, pterygopalatine fossa, and cribriform plate with 
the robotic arms. More importantly, they demonstrated the 
ability to perform watertight suturing of the anterior cranial 
fossa dura with the surgical robot. Some of the dissection was 
performed with prototype instruments that can remove bone in 
the skull base (E Hanna, personal communication, December 
2013). These prototype instruments, unfortunately, have not 
been marketed and are not available for clinical use.
In 2010, Lee et al reported their investigation of various 
approaches to the skull base with the da Vinci surgical robot 
on cadaveric dissection.71 They commented that with transoral 
route and elevation of the soft palate, a 0-degree lens would be 
adequate for visualization of lesions in the foramen magnum 
level. For lower and middle clivus, a 30-degree upward-
looking telescope setup would be required. Using a small 
8.5 mm 30-degree telescope, they could visualize the sella 
after removing the anterior sphenoid wall and sphenoid floor 
with conventional endoscopic drills. Unfortunately, clutter of 
robotic arms limited the range of movements of the robotic 
arms. In an effort to circumvent the clutter of robotic arms, 
the group had previously described placement of two ports 
through the submandibular soft tissue facing superiorly and 
allowed placing the two robotic arms outside the oral cavity 
angled superiorly.71,72 McCool et al also described a similar 
setup in which the third robotic arm was placed in the port 
inserted above the hyoid bone into the oropharynx.73
Ozer and Waltonen described the first robotic nasopha-
ryngectomy on a cadaver.74 To improve visualization of 
the nasopharynx, the soft palate was split in the midline 
and retracted laterally. They were able to resect the entire 
nasopharynx mucosa and both eustachian tube openings to 
expose the clivus and prevertebral fascia. The authors com-
mented that the potential advantages of the robotic approach 
included no facial incisions and no osteotomies.
Dallan et al performed cadaveric dissection for robotic 
nasopharyngectomy using the submandibular ports and 
0-degree endoscope introduced through one nostril.75 
They commented that this approach offered a better 
visualization of the roof of the nasopharynx and reduced 
conflicts of the robotic instruments and endoscope during 
the dissection.
Wei and Ho described the first clinical case of robotic 
nasopharyngectomy for recurrent nasopharyngeal carcinoma 
through a transoral approach.76 The approach was similar 
to the approach described by Ozer and Waltonen in their 
cadaveric dissection experiments.74 Since then, there have 
been further reports on the development of robotic nasopha-
ryngectomy, including combined approach with endoscopic 
endonasal approach.77,78 Tsang et al reported the first clinical 
case series of 12 patients who underwent robotic nasopha-
ryngectomy for small recurrent cancer. The early results were 
comparable with open surgery with less morbidity.79
O’Malley et al first described the use of TORS to resect 
parapharyngeal space tumors.69 Since then, there have been 
several large case series reporting the use of TORS for parapha-
ryngeal tumors. Chan et al performed a systematic review of 
the use of TORS in resection of parapharyngeal tumors.80 They 
concluded that the advantages of using TORS compared to 
transcervical approach included the absence of a neck scar and 
absence of first bite syndrome after operation. Unfortunately, 
TORS approach needs an incision through the oropharyngeal 
mucosa and superior constrictor muscles and higher rate of 
capsule rupture during dissection. TORS for resection of 
parapharyngeal tumors may be advantageous in lesions situated 
medial to the carotid vessels. An external approach will require 
retraction of the carotid vessels for exposure and resection of 
the lesion, which has its associated risks. Vidhyadharan et al 
reported the use of TORS for resection of a second branchial 
arch cyst medial to the carotid vessels, and Ansarin et al reported 
a series of parapharyngeal space tumors in the post-styloid 
compartment resected with TORS approach.81,82
Challenges and future developments
The da Vinci surgical robot was not primarily designed to be 
deployed in the head and neck region. It is still too bulky to 
use in places like the anterior skull base. A new surgical robot 
(model: da Vinci Xi) with a smaller footprint and less chance 
of arms collision has already been launched in the market, 
but unfortunately has not been designed for transoral use and 
FDA approval for TORS has not been sought. Smaller robotic 
instruments with flexible or semiflexible arms are being 
designed.74,83 Flexible robots could be introduced through the 
oral cavity and turn upwards to operate in the nasopharynx, 
negating the requirement for a straight-line access for the 
current rigid robotic instruments. Richmon presented his 
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Table 1 List of transoral robotic procedures mentioned in the 
review, excluding cadaveric experiments
Robotic radical tonsillectomy
Robotic tongue base resection
Robotic supraglottic laryngectomy
Robotic partial laryngectomy
Robotic hypopharyngectomy
Robotic total laryngectomy
Robotic-assisted transoral laser excision (oropharynx, larynx,  
and hypopharynx)
Robotic-assisted insetting of flaps
Robotic microvascular anastomosis for free flaps
Robotic lingual tonsillectomy for sleep apnea
Robotic resection of parapharyngeal tumors
Robotic nasopharyngectomy
work on using the Flex® System robot to perform resection 
of the nasopharynx without transgressing the palate in a 
cadaver.84
Lack of tactile feedback is a major criticism of robotic 
surgery and this is also true for TORS. Robotic surgeons 
currently substitute the tactile sensation mainly with visual 
cues to a certain extent, but visual cues could not entirely 
replace tactile sensation. VerroTouch is an early attempt to 
produce an external add-on to the da Vinci surgical robot to 
provide haptic feedback to the operating surgeon.75,85 The 
system is not required to be built into the current da Vinci 
robot, but instead is an after-market add-on. The sensors are 
placed on the wands of the robotic instruments just distal to 
the mounting points of the robotic arms. The vibration actua-
tors are placed on the control handles of the console. As the 
robotic instruments slip or hit tissue, the sensor will sense 
the acceleration/deceleration. The electrical signals from the 
sensors will be filtered, amplified, and converted to vibrations 
in the actuators. The surgeon would be able to feel vibrations 
in the finger-tips. A small-scale survey of the advantage of 
the VerroTouch system has been completed by eleven robotic 
surgeons and the majority welcomed the addition of the haptic 
feedback, but none found it essential.
Development of robotic instruments for bone removal 
will definitely improve the application of the surgical robot 
in fields like spine surgery and anterior skull base surgery, 
where bone removal constitutes a significant proportion of 
the operation. Currently, traditional endoscopic drills and 
burs are used if bone removal is required during TORS for 
the skull base. Developing small-diameter articulated robotic 
drills and burs suitable for TORS is an engineering chal-
lenge. Alternatively, other approaches for bone removal may 
be more suitable for development into robotic  instruments. 
Ultrasonic aspirators like Sonopet (Stryker, Kalamazoo, 
MI, USA) can precisely remove bone and have been used in 
endoscopic endonasal skull base surgery.86 Currently, it is 
the small commercial demand that limits the development 
of robotic versions of these instruments.
The development of alternative energy-source instru-
ments for hemostasis and their integration with robotic 
instruments will be a welcomed invention. Currently, TORS 
that use only monopolar and bipolar cautery are mostly 
being using for hemostasis. The current robotic ultrasonic 
dissector is too bulky and lacks articulation. An ultrasonic 
dissector would be a better instrument for dissection around 
areas prone to bleeding like venous plexus in the pterygoid 
plexus and parapharyngeal space.
The surgical navigation system can overcome the difficulty 
of identifying and avoiding injury of vital structures, especially 
the internal carotid artery in robotic  nasopharyngectomy. The 
currently available optic or electromagnetic types of naviga-
tion systems in the market have difficulty in working with the 
surgical robot. A surgical robot with integrated navigation 
system is under active development and we should see clinical 
application in the near future.87
With the development of computer and imaging technol-
ogy, augmented reality in surgical imaging is now available 
for clinical use. Augmented reality allows for the images of 
radiology scans to be overlaid on the endoscopic view during 
operation. This will allow better identification of pathologies 
and critical neurovascular structures buried deep underneath 
normal tissues. Integration of augmented reality with surgical 
robots has been under research for some time and clinical 
products should be available soon.88
Conclusion
In nearly a decade of development, TORS has emerged from 
a niche experimental surgery to mainstream management of 
early cancers in the oropharynx. It also has limited use in 
resecting cancers in the larynx and hypopharynx, and tumors 
in the skull base. TORS for benign conditions, especially 
tongue base resection for obstructive sleep apnea, has rapidly 
been adopted. TORS can be considered as the continuation of 
the paradigm shift first initiated by endoscopic surgery. With 
the advancement of technology, newer surgical robots, espe-
cially ones designed for application in TORS, will emerge 
soon. With the advent of these new technologies, surgeons 
must be prepared for another paradigm shift.
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